← Browse by Condition
Medical Condition
metastatic malignant solid neoplasm
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1
NCT03907475 Phase 2
Recruiting
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Enrollment
115 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04693468 Phase 1
Recruiting
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
Enrollment
111 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT04119024 Phase 1
Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi
NCT05222620 Phase 2
Recruiting
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
Enrollment
90 pts
Location
United States
Sponsor
Mayo Clinic